MA (EU) number 
(Invented) 
name 
Strength 
Pharmaceutical 
Form 
Route of 
Administration 
Immediate 
Packaging 
Content 
(concentration) 
Pack size 
EU/1/17/1262/001  CRYSVITA   
10 mg/ml 
EU/1/17/1262/002  CRYSVITA   
20 mg/ml 
EU/1/17/1262/003  CRYSVITA   
30 mg/ml 
Solution for 
injection 
Solution for 
injection 
Solution for 
injection 
Subcutaneous use  vial (glass) 
Subcutaneous use  vial (glass) 
Subcutaneous use  vial (glass) 
1 ml 
1 ml 
1 ml 
1 vial  
1 vial  
1 vial  
 
 
 
 
 
 
